Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv for ADHD Maintenance in Children and Adolescents
NCT03662763Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2011
- Primary completion
- Aug 2013
- Countries
- 1
01
Overview
A Phase 3 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Maastricht University Medical Center+. Started Sep 2011; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03662763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662763.